We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Olympus

Manufactures optical and digital equipment for the healthcare and consumer electronics sectors, including endoscopy a... read more Featured Products: More products

Download Mobile App




Advanced Imaging Endoscopes to Revolutionize Detection and Treatment of Gastrointestinal Disorders

By HospiMedica International staff writers
Posted on 29 May 2025

The global incidence of colorectal cancer (CRC) is projected to rise by 60%, equating to more than 2. More...

2 million new cases and 1.1 million deaths by 2030. Enhanced detection and more precise diagnoses are crucial for reducing CRC mortality; however, precursor lesions, often tiny and easily missed, present a significant challenge. A new advanced endoscopy system is transforming the detection, characterization, and treatment of gastrointestinal (GI) disorders, featuring innovative and user-friendly diagnostic and therapeutic technologies alongside improved scope handling.

Olympus Corporation (Tokyo, Japan) has introduced its EZ1500 series endoscopes, equipped with Extended Depth of Field (EDOF) technology, as part of the EVIS X1 endoscopy system. This breakthrough imaging technology enables clinicians to capture sharp, clear images, ensuring that the entirety of a lesion stays in focus. This could improve lesion detection as endoscopists examine the mucosal lining of the GI tract. EDOF technology works by splitting light entering the endoscope lens into two beams—one near-focused and the other far-focused—using two prisms. Both beams are then projected simultaneously onto an image sensor and combined into one comprehensive image with a broad depth of field. Compared to Olympus' previous scopes, this technology enhances visibility while reducing image blurring.

The EDOF endoscopes, including the GIF-EZ1500 gastroscope and CF-EZ1500DL/I colonoscope, offer a closer working distance in normal mode (3mm versus the 5mm of the CF-HQ190L/I) without sacrificing image quality, minimizing the need to switch to near mode. Additionally, these scopes feature the lightweight ErgoGrip control section, as well as compatibility with advanced imaging technologies like Texture and Color Enhancement Imaging (TXI™), Red Dichromatic Imaging (RDI), and Narrow Band Imaging (NBI) when connected to the EVIS X1 CV-1500 video system center. The ErgoGrip control section is 10% lighter than that of the 190 series, with a rounded handle and easy-to-reach angulation control knobs and switches, designed to improve maneuverability and support users with smaller hands. Olympus has received FDA 510(k) clearance for its EZ1500 series endoscopes, equipped with EDOF technology.

"As a leading global MedTech company, Olympus remains committed to providing advanced options to help physicians offer their patients the best care possible," said Kurt Heine, Senior Vice President and General Manager for Gastrointestinal Solutions at Olympus Corporation. "Our goal is to elevate the standard of endoscopy, and Extended Depth of Field (EDOF) technology represents Olympus' most advanced scope technology to help physicians drive the best clinical outcomes for advancing gastrointestinal procedures."


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The investigational niia signature wearable patch combines continuous glucose monitoring, insulin delivery, and automated glucose control in a single system. (photo courtesy of PharmaSens)

Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery

Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.